HA
HHLR Advisors Portfolio holdings
AUM
$3.1B
This Quarter Return
-13.14%
1 Year Return
+44.54%
3 Year Return
+121.93%
5 Year Return
+166.86%
10 Year Return
–
AUM
$2.89B
AUM Growth
+$2.89B
(-37%)
Cap. Flow
-$919M
Cap. Flow
% of AUM
-31.83%
Top 10 Holdings %
Top 10 Hldgs %
86.48%
Holding
52
New
4
Increased
10
Reduced
11
Closed
7
Top Buys
| 1 |
WNS Holdings
WNS
|
$72.6M |
| 2 |
API
Agora
API
|
$8.73M |
| 3 |
KE Holdings
BEKE
|
$7.23M |
| 4 |
Futu Holdings
FUTU
|
$5.38M |
| 5 |
TSMC
TSM
|
$4.58M |
Top Sells
| 1 |
Alibaba
BABA
|
$334M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$254M |
| 3 |
Pinduoduo
PDD
|
$198M |
| 4 |
Trip.com Group
TCOM
|
$59.1M |
| 5 |
ZTO Express
ZTO
|
$50.2M |
Sector Composition
| 1 | Healthcare | 39.96% |
| 2 | Consumer Discretionary | 34.86% |
| 3 | Communication Services | 8.29% |
| 4 | Real Estate | 7.18% |
| 5 | Technology | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
1
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $703M | 24.34% | 3,804,406 -1,372,500 | -27% | -$254M |
|
|
2
Alibaba
BABA
$322B
| $414M | 14.35% | 4,887,300 -3,940,300 | -45% | -$334M |
|
|
3
Pinduoduo
PDD
$171B
| $265M | 9.17% | 2,730,275 -2,036,505 | -43% | -$198M |
|
4
NetEase
NTES
$86.2B
| $231M | 8% | 2,588,943 | – | – |
|
|
5
KE Holdings
BEKE
$20.8B
| $207M | 7.18% | 11,261,276 +392,588 | +4% | +$7.23M |
|
6
Vipshop
VIPS
$8.25B
| $200M | 6.94% | 14,880,002 -840,320 | -5% | -$11.3M |
|
7
Legend Biotech
LEGN
$6.41B
| $195M | 6.74% | 5,984,550 -651,946 | -10% | -$21.2M |
|
8
ArriVent BioPharma
AVBP
$776M
| $119M | 4.14% | 4,484,672 | – | – |
|
|
9
Futu Holdings
FUTU
$25.8B
| $89.5M | 3.1% | 1,118,303 +67,214 | +6% | +$5.38M |
|
|
10
WNS Holdings
WNS
$3.24B
| $72.6M | 2.51% | +1,531,466 | New | +$72.6M |
|
|
11
Trip.com Group
TCOM
$48.2B
| $62.7M | 2.17% | 913,842 -860,590 | -48% | -$59.1M |
|
12
JD.com
JD
$44.1B
| $58.6M | 2.03% | 1,690,000 +90,000 | +6% | +$3.12M |
|
|
ENFN
13
DELISTED
Enfusion, Inc.
ENFN
| $51.2M | 1.77% | 4,975,183 | – | – |
|
14
Cytek Biosciences
CTKB
$527M
| $43.2M | 1.5% | 6,657,030 | – | – |
|
15
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $31.3M | 1.08% | 1,582,635 | – | – |
|
16
BridgeBio Pharma
BBIO
$9.89B
| $28.1M | 0.97% | 1,023,950 | – | – |
|
|
YSG
17
Yatsen Holding
YSG
$877M
| $27.4M | 0.95% | 6,885,873 -101,966 | -1% | -$406K |
|
|
CTNM
18
Contineum Therapeutics
CTNM
$293M
| $9.81M | 0.34% | 669,337 | – | – |
|
|
API
19
Agora
API
$313M
| $8.73M | 0.3% | +2,098,553 | New | +$8.73M |
|
|
20
ZTO Express
ZTO
$14.6B
| $8.52M | 0.3% | 435,927 -2,567,081 | -85% | -$50.2M |
|
|
21
TSMC
TSM
$1.2T
| $8.41M | 0.29% | 42,588 +23,193 | +120% | +$4.58M |
|
|
SOHU
22
Sohu.com
SOHU
$483M
| $6.73M | 0.23% | 510,484 -202,916 | -28% | -$2.67M |
|
|
IMAB
23
I-MAB
IMAB
$340M
| $5.08M | 0.18% | 5,980,568 -928,652 | -13% | -$789K |
|
24
Gossamer Bio
GOSS
$562M
| $4.5M | 0.16% | 4,974,041 | – | – |
|
25
Sagimet Biosciences
SGMT
$244M
| $3.26M | 0.11% | 724,800 | – | – |
|